We address the inefficiency of clinical trial success that is currently at >90% failure rate.
Simmunome is at the leading edge of leveraging AI towards unraveling biological complexity. We transform physiological systems into biologically representative computational models for use in therapeutic and preventative drug discovery. Despite the significant technological advances in biotechnology, high-throughput methods, and computational biology over the last 20 years, it has proven difficult to gain meaningful insights that translate into truly disruptive medicines.
We combine fragmented data to create holistic models of disease that translate to helping you understand your drug's mechanism of action, increase efficacy in the right target population and predict your drug's safety profile. Ultimately getting you to market faster, reducing your R&D costs, and dramatically increasing your probability of success.
Company Details
- Employees
- 11
- Founded
- -
- Address
- Montréal, Quebec, Ca
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.simmunome.com
- Keywords
- Tedy.
- HQ
- Montréal, Quebec
Simmunome Inc. Questions
Simmunome Inc.'s website is http://www.simmunome.com
Simmunome Inc.'s LinkedIn profile is https://ca.linkedin.com/company/simmunome
Simmunome Inc. has
11 employees.
View email and phone details for 11
employees at Simmunome Inc..
Simmunome Inc.'s industry is
Biotechnology Research
Simmunome Inc.'s top competitors are
Elephascare,
Agentnoon,
9bio Therapeutics,
Waveshaper Ai,
Conelabs,
Happly.ai,
Singularity Health,
Tedy,
Neiges Biotechnologies,
Marketmind™ Investor Relations.
Simmunome Inc.'s categories are Biotechnology Research
Simmunome Inc.'s founding year is 2019
